Pure Global
NCT05231707

Simunye: A Couples-focused Intervention for HIV Prevention and Care in South Africa

A Couples-focused Intervention for HIV Prevention and Care in South Africa
University of Michigan·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
A couples-focused intervention for HIV prevention and care in South Africa
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Michigan
Location
Sweetwaters, South Africa
Timeline & enrollment
Phase
N/A
Start date
Apr 29, 2022
End date
Jul 01, 2024
Enrollment
544 participants
Primary outcome

Virologic suppression change

Summary

From a sample of 272 male-female couples (544 individuals, 272 men and 272 women) recruited
 from rural KaZulu-Natal, South Africa, couples will be randomized to receive either
 individual a package of dyadic counseling and testing (intervention arm) or an attention
 matched control. The research examines the impact of a package of dyadic counseling and
 testing on viral suppression and engagement in HIV care among sero-discordant and concordant
 positive male-female couples in KwaZulu-Natal, South Africa.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05231707
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05231707 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 544 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.